GERN (STOCKS)
Geron Corp
$1.460000
-0.075000 (-4.89%)
Prev close: $1.535000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Harout Semerjian, MBA
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $941.22M
- Employees
- 229
- P/E (TTM)
- -14.05
- P/B (TTM)
- 4.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.02 | $-0.01 | -0.0108 | -117.39% |
|
Mar 2026 (Q1)
|
$-0.01 | $-0.02 | +0.0111 | +52.61% |
|
Dec 2025 (Q4)
|
$-0.02 | $-0.03 | +0.0123 | +38.08% |
|
Sep 2025 (Q3)
|
$-0.03 | $-0.03 | +0.0037 | +10.98% |
Financial Statements
| Revenues | $204.56M |
| Benefits Costs and Expenses | $267.31M |
| Costs And Expenses | $256.32M |
| Operating Expenses | $256.32M |
| Selling, General, and Administrative Expenses | $154.96M |
| Depreciation and Amortization | $485.00K |
| Other Operating Expenses | $101.01M |
| Operating Income/Loss | -$51.77M |
| Income/Loss From Continuing Operations After Tax | -$67.61M |
| Income/Loss From Continuing Operations Before Tax | -$62.75M |
| Net Income/Loss | -$67.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$67.61M |
| Net Income/Loss Available To Common Stockholders, Basic | -$67.61M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.11 |
| Diluted Earnings Per Share | -$0.11 |
| Basic Average Shares | 668,707,906 |
| Diluted Average Shares | 668,707,906 |
| Assets | $519.01M |
| Current Assets | $486.34M |
| Inventory | $123.60M |
| Other Current Assets | $362.74M |
| Noncurrent Assets | $32.67M |
| Fixed Assets | $1.09M |
| Other Non-current Assets | $31.58M |
| Liabilities | $300.40M |
| Current Liabilities | $70.33M |
| Accounts Payable | $8.81M |
| Wages | $9.11M |
| Other Current Liabilities | $52.42M |
| Noncurrent Liabilities | $230.06M |
| Equity | $218.61M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $218.61M |
| Liabilities And Equity | $519.01M |
| Net Cash Flow From Operating Activities | -$114.38M |
| Net Cash Flow From Operating Activities, Continuing | -$114.38M |
| Net Cash Flow From Investing Activities | $94.64M |
| Net Cash Flow From Investing Activities, Continuing | $94.64M |
| Net Cash Flow From Financing Activities | $4.73M |
| Net Cash Flow From Financing Activities, Continuing | $4.73M |
| Exchange Gains/Losses | -$70.00K |
| Net Cash Flow | -$15.07M |
| Net Cash Flow, Continuing | -$15.00M |
| Comprehensive Income/Loss | -$68.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$68.07M |
| Other Comprehensive Income/Loss | -$68.07M |